Remote monitoring of congestive heart failure and COPD patients may lower readmission rate

Share this article:
A pilot program using remote medical monitoring for recently hospitalized congestive heart failure and chronic obstructive pulmonary disease patients resulted in a lower readmission rate, Crain's Detroit Business reported.

Patients in the pilot study had a 3% readmission rate versus 25% for those who were not telemonitored. Pilot study patients were outfitted with remote medical monitoring devices such as wireless weight scales, blood pressure cuffs and blood glucose meters. Home health nurses and therapists instructed patients on using the devices and monitored the data offsite daily. If a patient hadn't entered information by a set deadline, nurses followed up with phone calls to check on the patient. Michigan-based company Residential Home Health LLC conducted the study. Often, seniors with congestive heart failure and COPD are discharged from hospitals to post-acute or skilled-nursing facilities, where blood pressure, weight and glucose levels are closely monitored. Closer coordination here can prevent hospital readmission.

Telemonitoring has its critics. "The technology can help, but we have to look at our workflow and make sure we coordinate care with post-acute providers to keep patients out of the hospital," said Christopher Kim, M.D., a hospitalist at University of Michigan Hospitals, told Crain's.

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.